All content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.
Every peptide covered here, with its mechanism class, legal status and WADA status. This is a status register, not a shop: no suppliers, no doses, no efficacy claims.
21 of 21
Components:AOD-9604 6 mgCJC-1295 3 mgIpamorelin 3 mg
Combination of AOD-9604 with a GHRH analogue and a ghrelin receptor agonist; the mixture itself has not been studied clinically.
Legal status applies per component
Components:BPC-157 5 mgTB-500 5 mg
Combination of two peptides studied in preclinical tissue repair models; neither component is approved anywhere.
Legal status applies per component
Components:BPC-157 10 mgTB-500 Fragment (17-23) 10 mg
Combination of BPC-157 with the shortened thymosin beta-4 fragment (17-23); no approval and no study of the mixture.
Legal status applies per component
Components:Cagrilintide 5 mgSemaglutide 5 mg
Combination of an amylin analogue with a GLP-1 receptor agonist; studied as a fixed combination in trials, not approved.
Legal status applies per component
Components:Cartalax 10 mgTB-500 5 mgBPC-157 5 mg
Combination of a Khavinson bioregulator with two tissue repair research peptides; no approval and no study of the mixture.
Legal status applies per component
Components:CJC-1295 No DAC 5 mgIpamorelin 5 mg
Combination of a GHRH analogue without DAC with a selective ghrelin receptor agonist; the mixture holds no approval.
Legal status applies per component
Components:CJC-1295 5 mgGHRP-2 5 mg
Combination of a GHRH analogue with a growth-hormone-releasing peptide; the mixture holds no approval.
Legal status applies per component
Components:CJC-1295 DAC 2 mgIpamorelin 5 mg
Combination of the long-acting GHRH analogue CJC-1295 DAC with ipamorelin; neither component is approved.
Legal status applies per component
Components:GHK-Cu 60 mgBPC-157 10 mg
Combination of the copper peptide GHK-Cu with BPC-157; a cosmetic ingredient mixed with a research peptide, not approved as a medicine.
Legal status applies per component
Components:GHK-Cu 50 mgKPV 20 mg
Combination of the copper peptide GHK-Cu with the alpha-MSH fragment KPV; not approved as a medicine.
Legal status applies per component
Components:GHK-Cu 50 mgBPC-157 10 mgTB-500 10 mg
Combination of GHK-Cu with BPC-157 and TB-500; none of the components is approved as an injectable medicine.
Legal status applies per component
Components:GHK-Cu 50 mgBPC-157 10 mgTB-500 10 mgKPV 10 mg
Combination of GHK-Cu, BPC-157, TB-500 and KPV; none of the components is approved as an injectable medicine.
Legal status applies per component
Components:Retatrutide 10 mgEloralintide 2.5 mg
Combination of the triple GIP/GLP-1/glucagon agonist retatrutide with the amylin analogue eloralintide; both in phase 3, neither approved anywhere.
Legal status applies per component
Components:5-Amino-1MQ 10 mgMOTS-c 10 mgNAD+ 100 mg
Combination of 5-Amino-1MQ, MOTS-c and NAD+, each studied separately in research on mitochondrial metabolism.
Legal status applies per component
Components:N-Acetyl Semax Amidate 20 mgPE-22-28 10 mgPinealon (EDR Tripeptide) 10 mgN-Acetyl Selank Amidate 8 mg
Combination of four neuropeptides from Russian research; no human trials of the mixture and no approval.
Legal status applies per component
Components:PT-141 (Bremelanotide) 10 mgMelanotan II 10 mg
Combination of two melanocortin receptor agonists; PT-141 is an approved medicine in the US, Melanotan II is not approved anywhere.
Legal status applies per component
Components:Selank 10 mgSemax 10 mg
Combination of the tuftsin analogue selank with the ACTH (4-10) fragment semax; both are registered as medicines only in Russia.
Legal status applies per component
Components:TB-500 (Thymosin β4) 5 mgBPC-157 (Body Protection Compound-157) 5 mg
Combination of two peptides studied in preclinical tissue repair models; sold as one vial, with no approval.
Legal status applies per component
Components:Tesamorelin 5 mgIpamorelin 5 mg
Combination of an approved GHRH analogue with an unapproved ghrelin receptor agonist; the mixture holds no approval.
Legal status applies per component
Components:Tesamorelin 6 mgIpamorelin 3 mgCJC-1295 No DAC 3 mg
Combination of two GHRH analogues with a selective growth hormone secretagogue; the mixture holds no approval.
Legal status applies per component
Components:TB-500 25 mgBPC-157 10 mgKPV 10 mg
Combination of TB-500, BPC-157 and KPV, whose components are studied in preclinical tissue repair models; no approval.
Legal status applies per component
Track doses, plans and progress on your phone — end-to-end encrypted.
This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.
